LINC00313 functions as an oncogenic propellant and immunosuppressive marker in lung adenocarcinoma
In conclusion, LINC00313 holds potential as a valuable biomarker and therapeutic target for the treatment of LUAD. However, further research is warranted to fully elucidate its clinical applications.
Authors
- Yanhui Cui (ORCID: https://orcid.org/0000-0001-9052-848X)
- Wen Wang (ORCID: https://orcid.org/0000-0003-3215-3020)
- Guoli Li (ORCID: https://orcid.org/0000-0003-0450-2529)
- Jianfu Heng
Institutions
- Central South University (CN)
- Hunan Normal University (CN)
- Hunan Provincial Center for Disease Control and Prevention (CN)
- Hunan Cancer Hospital (CN)
- Hunan Provincial People's Hospital (CN)
- Colorado Kidney Care (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1080/20565623.2025.2547557
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Hunan Province
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province